Compare KRT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | FDMT |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 515.6M |
| IPO Year | 2019 | 2019 |
| Metric | KRT | FDMT |
|---|---|---|
| Price | $29.09 | $9.64 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $26.50 | ★ $31.71 |
| AVG Volume (30 Days) | 76.3K | ★ 755.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.10% | N/A |
| EPS Growth | 4.70 | ★ 18.79 |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $467,743,000.00 | $85,209,000.00 |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $8.11 | $70.28 |
| P/E Ratio | $18.91 | ★ N/A |
| Revenue Growth | 10.67 | ★ 230194.60 |
| 52 Week Low | $20.61 | $2.89 |
| 52 Week High | $32.68 | $12.34 |
| Indicator | KRT | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 63.19 | 52.29 |
| Support Level | $27.11 | $8.41 |
| Resistance Level | $29.48 | $10.19 |
| Average True Range (ATR) | 0.75 | 0.69 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 68.89 | 49.59 |
Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).